Literature DB >> 9917632

Expression of bone morphogenetic proteins in fracture healing.

M P Bostrom1.   

Abstract

Fracture healing involves a complex interaction of many local and systemic regulatory factors. Recently, the presence of several bone morphogenetic proteins and their receptors in the fracture healing process has been described. During the early stages of fracture healing, only a minimum number of primitive cells are expressing bone morphogenetic proteins in the fracture callus. As the process of endochondral ossification proceeds, the presence of bone morphogenetic proteins and their receptors increases dramatically, especially in the primitive mesenchymal and chondrocytic cells. While the cartilaginous component of the callus matures with a concomitant decrease in the number of primitive cells, there is a concomitant decrease in presence of bone morphogenetic protein expressing cells. As osteoblasts start to lay down woven bone on the chondroid matrix, these osteoblastic cells express bone morphogenetic proteins and their receptors. The presence of bone morphogenetic proteins decreases, however, as lamellar bone replaces the primitive woven bone. A similar observation is seen in the areas of the callus undergoing intramembranous ossification. Initially, within several days after the fracture, periosteal cells and osteoblasts show intense expression of bone morphogenetic proteins and their receptors. As the woven bone is replaced with mature lamellar bone, the expression of bone morphogenetic protein decreases. These data and the knowledge of bone morphogenetic proteins' strong osteoinductive capacities suggest that individual bone morphogenetic proteins play important yet different roles during fracture repair.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9917632     DOI: 10.1097/00003086-199810001-00013

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  31 in total

1.  Fracture repair in the elderly: Clinical and experimental considerations.

Authors:  E G Meinberg; D Clark; K R Miclau; R Marcucio; T Miclau
Journal:  Injury       Date:  2019-05-11       Impact factor: 2.586

2.  Is the expression of Transforming Growth Factor-Beta1 after fracture of long bones solely influenced by the healing process?

Authors:  Georg Kaiser; Anita Thomas; Julia Köttstorfer; Mathias Kecht; Kambiz Sarahrudi
Journal:  Int Orthop       Date:  2012-05-24       Impact factor: 3.075

3.  Effect of platelet-rich plasma combined with demineralised bone matrix on bone healing in rabbit ulnar defects.

Authors:  Vasilios Galanis; Alice Fiska; Stylianos Kapetanakis; Konstantinos Kazakos; Thespis Demetriou
Journal:  Singapore Med J       Date:  2016-05-19       Impact factor: 1.858

Review 4.  Infection and tissue engineering in segmental bone defects--a mini review.

Authors:  Manitha B Nair; James D Kretlow; Antonios G Mikos; F Kurtis Kasper
Journal:  Curr Opin Biotechnol       Date:  2011-02-25       Impact factor: 9.740

5.  Combined use of low-intensity pulsed ultrasound and rhBMP-2 to enhance bone formation in a rat model of critical size defect.

Authors:  Siddhesh R Angle; Kotaro Sena; Dale R Sumner; Walter W Virkus; Amarjit S Virdi
Journal:  J Orthop Trauma       Date:  2014-10       Impact factor: 2.512

6.  Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model.

Authors:  Zarana S Patel; Simon Young; Yasuhiko Tabata; John A Jansen; Mark E K Wong; Antonios G Mikos
Journal:  Bone       Date:  2008-07-14       Impact factor: 4.398

7.  Gene therapy to improve osteogenesis in bone lesions with severe soft tissue damage.

Authors:  Tim Rose; Hairong Peng; Arvydas Usas; Ryosuke Kuroda; Helmut Lill; Freddie H Fu; Johnny Huard
Journal:  Langenbecks Arch Surg       Date:  2003-09-20       Impact factor: 3.445

Review 8.  Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis.

Authors:  Z S Ai-Aql; A S Alagl; D T Graves; L C Gerstenfeld; T A Einhorn
Journal:  J Dent Res       Date:  2008-02       Impact factor: 6.116

9.  Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2.

Authors:  Zarana S Patel; Masaya Yamamoto; Hiroki Ueda; Yasuhiko Tabata; Antonios G Mikos
Journal:  Acta Biomater       Date:  2008-04-22       Impact factor: 8.947

Review 10.  Mechanics and mechano-biology of fracture healing in normal and osteoporotic bone.

Authors:  Peter Augat; Ulrich Simon; Astrid Liedert; Lutz Claes
Journal:  Osteoporos Int       Date:  2004-09-15       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.